The FDA has granted 510(k) clearance to Vasoptic Medical Inc.’s XyCAM RI device, according to a press release.
The noninvasive retinal imager captures dynamic blood flow information, allowing assessment of retinal vasculature.
“The XyCAM RI adds to the clinician’s toolbox an ability to capture dynamic physiological information that can meaningfully improve their understanding of the condition and disease progression,” M. Jason Brooke, Vasoptic cofounder and general counsel, said. “It is our hope that clinicians in the future will leverage the blood flow information
Uncategorized